SPORE Archives
STINGing combination for cancer
Jun. 19, 2017—A novel immunotherapy combination induced remarkable regression of tumors in a mouse model of head and neck cancer.
New direction for treating lung cancer
Feb. 7, 2014—Targeting the production of molecules that promote tumor blood vessel development offers a new path for treating lung cancer.
Vanderbilt, GE unite to study colon tumor development
Jan. 31, 2013—Vanderbilt University has partnered with GE Global Research in Niskayuna, N.Y., the technology development arm of the General Electric Company, to better define — at the cellular level — how colon tumors form and develop.
Vanderbilt identifies genes linked to breast cancer chemo resistance
Jun. 11, 2012—A study led by Vanderbilt-Ingram Cancer Center investigators has identified a gene expression pattern that may explain why chemotherapy prior to surgery isn’t effective against some tumors and suggests new therapy options for patients with specific subtypes of breast cancer.
